Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics.
Morgan
E T
ET
Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia, USA. etmorga@emory.edu
D000818:Animals; D003141:Communicable Diseases / Q000201:enzymology* / Q000473:pathology*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D015536:Down-Regulation / Q000502:physiology; D004347:Drug Interactions / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D018836:Inflammation Mediators / Q000502:physiology*; D004364:Pharmaceutical Preparations / Q000378:metabolism*
D018836:Inflammation Mediators; D004364:Pharmaceutical Preparations; D003577:Cytochrome P-450 Enzyme System